Published in Lancet Infect Dis on April 20, 2011
Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J (2015) 6.18
Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis (2012) 1.81
Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005-2009. PLoS One (2011) 1.68
Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs). Allergy Asthma Proc (2012) 1.44
The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med (2016) 1.32
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J (2015) 1.18
Factors associated with latent tuberculosis among asylum seekers in Switzerland: a cross-sectional study in Vaud County. BMC Infect Dis (2012) 1.02
Screening for infectious diseases among newly arrived migrants in EU/EEA countries--varying practices but consensus on the utility of screening. Int J Environ Res Public Health (2014) 1.01
Engaging new migrants in infectious disease screening: a qualitative semi-structured interview study of UK migrant community health-care leads. PLoS One (2014) 0.98
Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study. BMJ Open (2012) 0.93
Immigrant screening for TB: a missed opportunity to improve TB control in the United Kingdom. Pathog Glob Health (2012) 0.92
QuantiFERON-TB gold in-tube implementation for latent tuberculosis diagnosis in a public health clinic: a cost-effectiveness analysis. BMC Infect Dis (2012) 0.92
Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection. Eur Respir J (2012) 0.91
Case series of extra pulmonary tuberculosis presenting as facial swelling. Br Dent J (2015) 0.89
Screening of imported infectious diseases among asymptomatic sub-Saharan African and Latin American immigrants: a public health challenge. Am J Trop Med Hyg (2015) 0.89
Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil. PLoS One (2013) 0.88
Tuberculosis in tropical areas and immigrants. Mediterr J Hematol Infect Dis (2014) 0.87
Gender disparities in latent tuberculosis infection in high-risk individuals: a cross-sectional study. PLoS One (2014) 0.86
Pre-entry screening for tuberculosis: the need for better evidence. Pathog Glob Health (2015) 0.85
Is screening immigrants for latent tuberculosis cost-effective? Lancet Infect Dis (2011) 0.84
High rates of Mycobacterium tuberculosis among socially marginalized immigrants in low-incidence area, 1991-2010, Italy. Emerg Infect Dis (2013) 0.84
Screening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK: a cross-sectional study. BMC Infect Dis (2014) 0.84
How methodologic differences affect results of economic analyses: a systematic review of interferon gamma release assays for the diagnosis of LTBI. PLoS One (2013) 0.83
Latent tuberculosis in healthcare workers: time to act. Oman Med J (2013) 0.80
Screening for Infectious Diseases among Newly Arrived Migrants: Experiences and Practices in Non-EU Countries of the Mediterranean Basin and Black Sea. Int J Environ Res Public Health (2015) 0.78
Transnational Record Linkage for Tuberculosis Surveillance and Program Evaluation. Public Health Rep (2015) 0.78
Mind the gap: TB trends in the USA and the UK, 2000-2011. Thorax (2016) 0.78
Description of the largest cluster of tuberculosis notified in Norway 1997-2011: is the Norwegian tuberculosis control programme serving its purpose for high risk groups? BMC Public Health (2015) 0.77
A scoping review of cost-effectiveness of screening and treatment for latent tubercolosis infection in migrants from high-incidence countries. BMC Health Serv Res (2015) 0.77
Screening of immigrants in the UK for latent tuberculosis. Expert Rev Respir Med (2011) 0.76
Cost-effectiveness of screening for active cases of tuberculosis in Flanders, Belgium. Bull World Health Organ (2016) 0.75
Predicting tuberculosis risk in the foreign-born population of British Columbia, Canada: study protocol for a retrospective population-based cohort study. BMJ Open (2016) 0.75
Improving Control of Tuberculosis in Low-Burden Countries: Insights from Mathematical Modeling. Front Microbiol (2016) 0.75
Treating latent TB in primary care: a survey of enablers and barriers among UK General Practitioners. BMC Infect Dis (2015) 0.75
'Pre-entry screening for tuberculosis' commentary: authors' response. Pathog Glob Health (2015) 0.75
Outcomes analysis of new entrant screening for active tuberculosis in Heathrow and Gatwick airports, United Kingdom 2009/2010. BMC Infect Dis (2016) 0.75
Missed opportunities for tuberculosis screening in primary care. J Pediatr (2015) 0.75
Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation. Eur Respir J (2017) 0.75
Migrants and Refugees in Europe: Challenges, Experiences and Contributions. Visc Med (2017) 0.75
Factors Influencing the Accuracy of Infectious Disease Reporting in Migrants: A Scoping Review. Int J Environ Res Public Health (2017) 0.75
Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis. Eur J Health Econ (2016) 0.75
Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet (2003) 8.30
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep (2010) 8.16
Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet (2005) 4.82
Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest (2009) 3.24
Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet (2001) 3.15
Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest (2007) 2.90
Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med (2008) 2.85
Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol (2002) 2.83
Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med (2000) 2.73
Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med (2010) 2.67
Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. Thorax (2002) 2.53
T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med (2010) 2.36
Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med (2008) 2.36
Rethinking TB screening: politics, practicalities and the press. Thorax (2010) 2.26
Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis (2009) 1.96
Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice. Eur Respir J (2010) 1.88
Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis (2007) 1.79
Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J (2009) 1.63
Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med (2000) 1.59
The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Dis (2009) 1.50
Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS One (2010) 1.45
The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One (2011) 1.42
A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect Dis (2011) 1.42
A 100 year update on diagnosis of tuberculosis infection. Br Med Bull (2009) 1.40
Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal. PLoS One (2010) 1.37
Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (2011) 1.35
Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child (2009) 1.29
Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med (2010) 1.23
Prevalence and risk factors for tuberculosis infection among hospital workers in Hanoi, Viet Nam. PLoS One (2009) 1.23
The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia. Am J Trop Med Hyg (2009) 1.22
Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest (2007) 1.21
Screening for tuberculosis infection among newly arrived asylum seekers: comparison of QuantiFERONTB Gold with tuberculin skin test. BMC Infect Dis (2008) 1.18
Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk. Am J Respir Crit Care Med (2000) 1.18
QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect (2007) 1.09
Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis. Int J Tuberc Lung Dis (2009) 1.07
Use of the QuantiFERON-TB Gold test for screening tuberculosis contacts and predicting active disease. Int J Tuberc Lung Dis (2010) 1.05
Tuberculosis in non-UK-born persons, England and Wales, 2001-2003. Int J Tuberc Lung Dis (2007) 1.04
Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden. Thorax (2010) 0.98
Risk-based screening for latent tuberculosis infection. South Med J (2008) 0.95
Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts. Clin Infect Dis (2009) 0.94
The outcome of a cohort of tuberculin-positive predominantly South Asian new entrants aged 16-34 to the UK: Blackburn 1989-2001. J Public Health (Oxf) (2013) 0.90
Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants. Infection (2010) 0.89
T-cell interferon-gamma release assays: can we do better? Eur Respir J (2008) 0.87
Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study. BMC Infect Dis (2009) 0.87
Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet (2003) 8.30
Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med (2005) 6.13
Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet (2005) 4.82
Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med (2005) 4.72
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis (2013) 4.26
Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med (2006) 3.98
Treatment of latent tuberculosis infection: a network meta-analysis. Ann Intern Med (2014) 3.57
Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS (2002) 3.47
Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis. Clin Infect Dis (2005) 3.35
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med (2014) 3.32
Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med (2006) 3.12
Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis (2013) 3.12
Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet (2004) 3.07
Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med (2013) 3.03
Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med (2008) 2.85
Retracted The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med (2006) 2.72
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine (2010) 2.66
Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study. Thorax (2011) 2.60
Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol (2007) 2.40
Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS (2005) 2.38
Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention. Clin Infect Dis (2003) 2.38
Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med (2008) 2.36
Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2013) 2.28
Rethinking TB screening: politics, practicalities and the press. Thorax (2010) 2.26
A comparison between two strategies for monitoring hepatic function during antituberculous therapy. Am J Respir Crit Care Med (2011) 2.22
Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm. AIDS (2011) 2.10
Comparing cannabis with tobacco. BMJ (2003) 2.08
Increased risk of Mycobacterium tuberculosis infection in household child contacts exposed to passive tobacco smoke. Pediatr Infect Dis J (2014) 1.97
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis (2012) 1.89
Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis (2004) 1.88
Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: a cohort of high-risk men who have sex with men. HIV Med (2009) 1.83
Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med (2010) 1.83
Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis (2012) 1.81
Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum. Am J Respir Crit Care Med (2009) 1.79
Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax (2013) 1.77
Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006. BMC Public Health (2010) 1.76
Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis (2012) 1.72
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med (2004) 1.70
Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin Microbiol Rev (2012) 1.68
Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis (2004) 1.68
The impact of economic crises on communicable disease transmission and control: a systematic review of the evidence. PLoS One (2011) 1.64
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis (2013) 1.62
Reversing the tide of the UK tuberculosis epidemic. Lancet (2013) 1.61
Investigating acupuncture using brain imaging techniques: the current state of play. Evid Based Complement Alternat Med (2005) 1.59
Bayesian modeling to unmask and predict influenza A/H1N1pdm dynamics in London. Proc Natl Acad Sci U S A (2011) 1.58
Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med (2005) 1.58
Clandestine induced abortion: prevalence, incidence and risk factors among women in a Latin American country. CMAJ (2009) 1.55
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis (2005) 1.47
Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS One (2010) 1.45
A comparison of the validity of different diagnostic tests in adults with asthma. Chest (2002) 1.36
Increasing antituberculosis drug resistance in the United Kingdom: analysis of National Surveillance Data. BMJ (2008) 1.36
Rhinovirus 16-induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol (2012) 1.35
Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (2011) 1.35
Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles. J Immunol (2004) 1.34
How much do delayed healthcare seeking, delayed care provision, and diversion from primary care contribute to the transmission of STIs? Sex Transm Infect (2007) 1.33
Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol (2006) 1.31
Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect Immun (2004) 1.30
Modelling the impact of local reactive school closures on critical care provision during an influenza pandemic. Proc Biol Sci (2011) 1.28
Appropriate evaluation of HIV prevention interventions: from experiment to full-scale implementation. Sex Transm Infect (2007) 1.26
Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLoS One (2011) 1.24
Economic crisis and communicable disease control in Europe: a scoping study among national experts. Health Policy (2011) 1.23
Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis. Thorax (2012) 1.21
Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection. Emerg Infect Dis (2013) 1.20
T-cell immunophenotyping distinguishes active from latent tuberculosis. J Infect Dis (2013) 1.18
Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice. J Antimicrob Chemother (2011) 1.16
Dedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation. BMJ (2011) 1.15
Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype. Thorax (2012) 1.14
Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. Am J Respir Crit Care Med (2011) 1.14
Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int (2004) 1.11
A new sentinel surveillance system for severe influenza in England shows a shift in age distribution of hospitalised cases in the post-pandemic period. PLoS One (2012) 1.11
Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries. Epidemics (2011) 1.10
Targeting vaccination against novel infections: risk, age and spatial structure for pandemic influenza in Great Britain. J R Soc Interface (2010) 1.08
Antimycobacterial, antiprotozoal and cytotoxic potential of twenty-one brown algae (Phaeophyceae) from British and Irish waters. Phytother Res (2010) 1.08
Interferon gamma assays for tuberculosis. Lancet Infect Dis (2005) 1.08
Importance of onsite cytopathology at endobronchial ultrasound. Am J Respir Crit Care Med (2013) 1.08
A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J Clin Invest (2011) 1.07
Multiple introductions of multidrug-resistant tuberculosis into households, Lima, Peru. Emerg Infect Dis (2011) 1.07
The visual analogue WOMAC 3.0 scale--internal validity and responsiveness of the VAS version. BMC Musculoskelet Disord (2010) 1.07
Developing a research strategy for acupuncture. Clin J Pain (2006) 1.05
The growing impact of HIV infection on the epidemiology of tuberculosis in England and Wales: 1999 2003. Thorax (2007) 1.05
BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. Vaccine (2009) 1.05
How does the level of BCG vaccine protection against tuberculosis fall over time? BMJ (2011) 1.04
A review of mathematical models of HIV/AIDS interventions and their implications for policy. Sex Transm Infect (2011) 1.02
IGRAs--the gateway to T cell based TB diagnosis. Methods (2013) 1.02
A geographically-restricted but prevalent Mycobacterium tuberculosis strain identified in the West Midlands Region of the UK between 1995 and 2008. PLoS One (2011) 1.01
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics (2007) 1.01